Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2023 (11)
  • 2022 (17)
  • 2021 (20)
  • 2020 (3)
  • 2019 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (557)
  • Synthetic drugs (346)
  • Seizures (Drugs/Property) (192)
  • Task Forces/Task Force Officers (182)
  • Guns/Weapons (174)
  • Major Law Enforcement Operation (147)
  • Overdose (121)
  • OCDETF/Task Force (91)
  • Arrests/Convictions - Major (87)
  • Prescription Drugs (80)
  • Gangs (79)
  • Fake Pills (67)
  • Diversion Division (57)
  • Guilty Plea (43)
  • Narcoterrorism (38)
  • Outreach/Drug Prevention (30)
  • Money Laundering (28)
  • Press Conferences (23)
  • Take Back Day (17)
  • Fentanyl Awareness (15)
  • One Pill Can Kill (13)
  • Public and Media Affairs - also see Congressional Affairs (12)
  • Dark Web- Internet Trafficking (10)
  • HIDTA (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Extraditions (8)
  • International/Foreign Operations (8)
  • Terrorism (7)
  • Asset Forfeiture (5)
  • Counterfeit Pills (4)
  • Fentanyl Free America (4)
  • Campaigns (2)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Cartel (1)
  • Critical Incident (1)
  • El Paso Intelligence Center (1)
  • Intelligence Division - Intelligence Products (1)
  • Pharmaceuticals/Pharmacists/Physicians (56)

Drug Name

  • Opioids (25)
  • Oxycodone (19)
  • Synthetic Opioids (10)
  • Fentanyl (9)
  • Hydromorphone (6)
  • Benzodiazepines (3)
  • Morphine (3)
  • Steroids (3)
  • Cocaine (2)
  • Heroin (1)
  • Ketamine (1)
  • Methadone (1)
  • Methamphetamine (1)

Field Division

  • St. Louis (32)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (10)
  • Seattle (9)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Louisville (6)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • Washington, DC (35)
  • New York (21)
Clear All Results
56 Results - Showing 1 to 10
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
PRESS RELEASE

2025 National Health Care Fraud Takedown

ALEXANDRIA, Va. – Erik S. Siebert, U.S. Attorney for the Eastern District of Virginia, announced criminal charges against six defendants. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown . The charges are part of a strategically coordinated, nationwide law...
PRESS RELEASE

Fort Salonga Urologist and Wife Charged with Criminal Sale of a Prescription for a Controlled Substance and Falsifying Business Records

SUFFOLK COUNTY, N.Y. – Suffolk County District Attorney Raymond A. Tierney and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III today announced the indictment of Francis and Jessica Martinis, of Fort Salonga, accused of Criminal Sale of Prescription for a Controlled Substance by a Practitioner and Falsifying...
PRESS RELEASE

Queens Pharmacist Sentenced to 60 Months in Prison for Illegally Distributing Oxycodone and Filing False Tax Returns

BROOKLYN, N.Y. - Today, Daniel E. Russo was sentenced to 60 months in prison by United States District Judge Dora L. Irizarry for conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. In...
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
PRESS RELEASE

Nurse Practitioner Arrested, Charged with Selling Oxymorphone

BUFFALO, N.Y. - U.S. Attorney Trini E. Ross announced today that Michael Ostolski, 55, of North Tonawanda, NY, was arrested and charged by criminal complaint with conspiracy to distribute oxymorphone. The charge carries a maximum penalty of 20 years in prison and a $1,000,000 fine. Assistant U.S. Attorney Michael J...
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
PRESS RELEASE

The United States and Montgomery County Based Pharmacy and Pharmacist Reach a Consent Decree Over Allegations of Illegally Dispensed Controlled Substances

Greenbelt, Maryland - U.S. District Judge Peter J. Messitte approved the United States’ consent decree with Abtin Youssefi-Rashti, a Montgomery County based pharmacist, and Upton Care Pharmacy, Inc. (“Upton Care”), resolving the United States’ civil allegations that Youssefi-Rashti and Upton Care violated the Controlled Substances Act (“CSA”) in illegally dispensing...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster